Most Recent
Clive Palmer’s nephew fails in appeal of contempt findings
The nephew of Clive Palmer and former director of Queensland Nickel has failed to reverse a decision rejecting his bid to dismiss contempt proceedings related to the company’s collapse.
Ex-Linchpin director loses appeal of $150,000 penalty
The director of collapsed investment firm Linchpin Capital has lost his challenge to a $150,000 penalty, with an appeals court dismissing his arguments as “carping criticism”.
Phoslock, KPMG to turn over info for possible shareholder class action
Water treatment company Phoslock and auditor KPMG and have agreed to produce documents for a possible shareholder class action, but a privilege fight may still be on the cards.
Advanta Seeds can’t force licensee Nuseed to fix seed labels
The developer of a Canola seed hybrid tolerant to herbicide has lost a bid for seed grower Nuseed to relabel its products, which are already stocked in 361 retail locations.
Captain Cook, ACCC to mediate after failed High Court appeal
Captain Cook College and its COO will attempt to reach an agreement on penalty with the ACCC after the High Court knocked back their appeal of a systemic unconscionable conduct finding.
‘Horse has bolted’: Judge declasses COVID-19 insurance class actions
Four proceedings over COVID-19 business interruption losses will be stripped of class action status, with a judge saying most of the common issues were already determined in test cases.
Super Retail hit with second Fair Work case in Federal Court
Super Retail faces a second Federal Court case by a former senior female executive, after conciliation proceedings in the Fair Work Commission failed to resolve the complaint.
Coles, Woolworths taken to court by ACCC over ‘illusory’ discounts
Major supermarkets Coles and Woolworths have been taken to court by the consumer regulator, accused of inflating prices for short periods in order to advertise more attractive discounts.
Medtronic penalised $22M over sale of bone graft kits without regulatory OK
Medical device supplier Medtronic has been socked with a $22 million penalty after it supplied non-compliant bone graft kits to hospitals, in what is the largest penalty under the Therapeutics Good Act.
Lundbeck wins appeal in decade-long IP battle with Sandoz over Lexapro
Pharmaceuticals giant Lundbeck has succeeded in overturning IP Australia’s decision granting Novartis unit Sandoz a licence to sell a generic version of top-selling antidepressant Lexapro.